Please use this identifier to cite or link to this item: https://hdl.handle.net/10419/232223 
Year of Publication: 
2020
Series/Report no.: 
Research Paper No. 103
Publisher: 
South Centre, Geneva
Abstract: 
As we observe the 18th anniversary of the Doha Declaration on the TRIPS Agreement (Agreement on Trade-Related Aspects of Intellectual Property Rights) and Public Health, it is appropriate to take stock of intellectual property developments and endeavour to present a comprehensive account of the situation in the African continent in respect of the implementation of TRIPS flexibilities, specifically those regarding access to medicines. This research paper provides an overview of the extent to which selected African countries have adopted legal and policy frameworks with regard to TRIPS flexibilities, examines the actual use of these flexibilities in enabling access to medicines in those countries, and suggests some recommendations for optimising the use of the flexibilities in pursuing public health imperatives.
Subjects: 
Access to Medicines
Affordable Medicines
Africa
African Regional Intellectual Property Organization (ARIPO)
Bolar
Competition Law
Competition Policy
Compulsory Licenses
Doha Declaration on the TRIPS Agreement and Public Health
East African Community (EAC)
Flexibilities
Government Use
Health
Industrial Property
Innovation
Intellectual Property
Least Developed Countries (LDCs)
Parallel Imports
Patent
Patent Examination
Patent Linkage
Patent Term
Patentability Criteria
Post-Grant Opposition
Pre-Grant Opposition
Public Health
Research and Development (R&D)
Research Exception
Southern African Development Community (SADC)
TRIPS
TRIPS-Plus Provisions
World Trade Organization (WTO)
WTO
Document Type: 
Research Report
Appears in Collections:

Files in This Item:
File
Size





Items in EconStor are protected by copyright, with all rights reserved, unless otherwise indicated.